Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 10
1963 2
1964 3
1965 5
1967 3
1968 2
1969 3
1970 7
1971 3
1972 6
1973 6
1974 8
1975 5
1976 7
1977 5
1978 2
1979 10
1980 10
1981 7
1982 10
1983 10
1984 8
1985 10
1986 18
1987 13
1988 14
1989 23
1990 24
1991 31
1992 34
1993 38
1994 50
1995 72
1996 90
1997 117
1998 131
1999 117
2000 168
2001 192
2002 222
2003 293
2004 335
2005 421
2006 467
2007 620
2008 626
2009 695
2010 864
2011 996
2012 1020
2013 1079
2014 1128
2015 1201
2016 1216
2017 1251
2018 1312
2019 1339
2020 1550
2021 1687
2022 1578
2023 1458
2024 1516
2025 1604
2026 1220
2027 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24,100 results

Results by year

Filters applied: . Clear all
Page 1
eIF4G2-Dependent Translation Restrains Pancreatic Cancer Progression.
Powers J, Wei L, Cheung JCT, Ahmadi P, Kobayashi H, Curiel-Garcia A, Kang S, Valenzuela E, Jovanovic M, Chavez A, Chio IIC. Powers J, et al. Among authors: kang s. Cancer Res. 2026 Aug 14;86(16):3920-3931. doi: 10.1158/0008-5472.CAN-25-4299. Cancer Res. 2026. PMID: 42202060 Free PMC article.
Predicting Risk of Cardiovascular Disease EVENTs Equation for Adverse Cardio-Kidney Outcomes in CKD Population.
Ko B, Jung CY, Ko YE, Koh HB, Park CH, Kim HW, Park JT, Han SH, Kang SW, Kim J, Kim YH, Sung S, Lee KB, Oh KH, Anderson AH, Yang W, Cohen JB, Rahman M, Jhee JH, Yoo TH; CRIC (Chronic Renal Insufficiency Cohort) and KNOW-CKD (KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease) Investigators. Ko B, et al. Among authors: kang sw. Clin J Am Soc Nephrol. 2026 Aug 1;21(8):1310-1325. doi: 10.2215/CJN.0000001078. Epub 2026 May 26. Clin J Am Soc Nephrol. 2026. PMID: 42189599 Free PMC article.
Ocular Symptoms After Refractive Surgery.
Kang S, Betz JD, Locatelli EVT, Everist SJ, Perez-Blanco M, Harkness BM, Huang JJ, Chamberlain WD, Tonk RS, Culbertson WW, Stutzman RD, Nanji AA, Aicher SA, Galor A, Yoo SH. Kang S, et al. JAMA Ophthalmol. 2026 Aug 1;144(8):733-743. doi: 10.1001/jamaophthalmol.2026.2500. JAMA Ophthalmol. 2026. PMID: 42424051
Cigarette smoke induces FASN-dependent fatty acid metabolic rewiring to drive bladder cancer progression.
Amara CS, Piyarathna DWB, Kamal AHM, Chan YS, Kami Reddy KR, Ambati CSR, Hassan MK, Shriwas P, Gandhi T, Jain A, Gangnus T, Popli P, Borkar R, Kang SW, Summers SL, Putluri V, Grimm SL, Venkatesh S, Song N, Seeley EH, Hedlich-Dwyer J, Chen SH, Mahajan NP, Jain AK, Dobrolecki LE, Wells GA, Villanueva H, Li J, Liu X, Bollag RJ, Malovannaya A, Jung SY, Lee HS, Asangani IA, Terris MK, Creighton CJ, Ballester LY, Karanam B, Liu S, Lee M, Raju RR, Siddiqui MM, Eberlin LS, Kommagani R, Sreekumar A, Gao J, Young NL, Hodges HC, Coarfa C, Gassman NR, Lerner SP, Lotan Y, Putluri N. Amara CS, et al. Among authors: kang sw. Cancer Lett. 2026 Aug 10;653:218562. doi: 10.1016/j.canlet.2026.218562. Epub 2026 May 4. Cancer Lett. 2026. PMID: 42092682 Free PMC article.
Aggregation and propagation of TAF15 trigger neurodegeneration.
Meng L, Liu C, Gong H, Gao Y, Li M, Liu H, Teng H, Xiong M, Liu H, Yan M, Hong DK, Kang SS, Xiong J, Zhang Z. Meng L, et al. Among authors: kang ss. Neuron. 2026 Aug 19;114(16):2987-3002.e8. doi: 10.1016/j.neuron.2026.06.022. Epub 2026 Aug 6. Neuron. 2026. PMID: 42561933
Multimodal blood based proteomic profiling reveals insights into mechanisms of immunotherapy resistance.
Wright SJ, Zamora I, Parikh M, Yeramosu D, Rucevic M, Sade-Feldman M, LaSalle TJ, Blaum EM, Liu B, Bi L, Kang S, Blum SM, Nguyen N, Guess J, Kar A, Schneider AM, Lieb D, Woods E, Michaud W, Lawless AR, Sharova T, Cohen S, Kasumova G, Kim MS, Cheng LC, Villani AC, Park RJ, Jenkins RW, Klempner SJ, Sullivan RJ, Flaherty KT, Hacohen N, Mehta A, Boland GM. Wright SJ, et al. Among authors: kang s. Nat Commun. 2026 Jun 24;17(1):7946. doi: 10.1038/s41467-026-74790-7. Nat Commun. 2026. PMID: 42342704 Free PMC article.
Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.
Davids MS, Eyre TA, Woyach JA, Roeker LE, Ferrajoli A, Wang Y, Tam CS, Jurczak W, Zinzani PL, Šimkovič M, Li JY, Bosch F, Roos-Weil D, Cramer P, Osterborg A, Islam P, Jacobs R, Skarbnik A, Bhat SA, Kang S, Chen M, Nguyen B, McNeely SC, Chung KL, Oliveira JM, Ito R, Ghia P, Wierda WG. Davids MS, et al. Among authors: kang s. Lancet. 2026 Aug 1;408(10553):453-470. doi: 10.1016/S0140-6736(26)01204-3. Epub 2026 Jul 9. Lancet. 2026. PMID: 42425121 Free article. Clinical Trial.
24,100 results
You have reached the last available page of results. Please see the User Guide for more information.